Ventilation-induced brain injury in preterm neonates: A review of potential therapies

Samantha K. Barton, Mary Tolcos, Suzanne L. Miller, Charles Christoph Roehr, Georg M. Schmolzer, Timothy J. M. Moss, Stuart Brian Hooper, Euan M. Wallace, Graeme R. Polglase

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Mechanical ventilation is a risk factor for cerebral inflammation and brain injury in preterm neonates. The risk increases proportionally with the intensity of treatment. Recent studies have shown that cerebral inflammation and injury can be initiated in the delivery room. At present, initiation of intermittent positive pressure ventilation (IPPV) in the delivery room is one of the least controlled interventions a preterm infant will likely face. Varying pressures and volumes administered shortly after birth are sufficient to trigger pathways of ventilation-induced lung and brain injury. The pathways involved in ventilation-induced brain injury include a complex inflammatory cascade and haemodynamic instability, both of which have an impact on the brain. However, regardless of the strategy employed to deliver IPPV, any ventilation has the potential to have an impact on the immature brain. This is particularly important given that preterm infants are already at a high risk for brain injury simply due to immaturity. This highlights the importance of improving the initial respiratory support in the delivery room. We review the mechanisms of ventilation-induced brain injury and discuss the need for, and the most likely, current therapeutic agents to protect the preterm brain. These include therapies already employed clinically, such as maternal glucocorticoid therapy and allopurinol, as well as other agents, such as erythropoietin, human amnion epithelial cells and melatonin, already showing promise in preclinical studies. Their mechanisms of action are discussed, highlighting their potential for use immediately after birth.

Original languageEnglish
Pages (from-to)155-162
Number of pages8
JournalNeonatology
Volume110
Issue number2
DOIs
Publication statusPublished - Aug 2016

Keywords

  • Brain
  • Delivery room
  • Neonate
  • Resuscitation
  • Therapy
  • Ventilation

Cite this

@article{def9c3fb29e447f3b3ed8d4d819fdd18,
title = "Ventilation-induced brain injury in preterm neonates: A review of potential therapies",
abstract = "Mechanical ventilation is a risk factor for cerebral inflammation and brain injury in preterm neonates. The risk increases proportionally with the intensity of treatment. Recent studies have shown that cerebral inflammation and injury can be initiated in the delivery room. At present, initiation of intermittent positive pressure ventilation (IPPV) in the delivery room is one of the least controlled interventions a preterm infant will likely face. Varying pressures and volumes administered shortly after birth are sufficient to trigger pathways of ventilation-induced lung and brain injury. The pathways involved in ventilation-induced brain injury include a complex inflammatory cascade and haemodynamic instability, both of which have an impact on the brain. However, regardless of the strategy employed to deliver IPPV, any ventilation has the potential to have an impact on the immature brain. This is particularly important given that preterm infants are already at a high risk for brain injury simply due to immaturity. This highlights the importance of improving the initial respiratory support in the delivery room. We review the mechanisms of ventilation-induced brain injury and discuss the need for, and the most likely, current therapeutic agents to protect the preterm brain. These include therapies already employed clinically, such as maternal glucocorticoid therapy and allopurinol, as well as other agents, such as erythropoietin, human amnion epithelial cells and melatonin, already showing promise in preclinical studies. Their mechanisms of action are discussed, highlighting their potential for use immediately after birth.",
keywords = "Brain, Delivery room, Neonate, Resuscitation, Therapy, Ventilation",
author = "Barton, {Samantha K.} and Mary Tolcos and Miller, {Suzanne L.} and Roehr, {Charles Christoph} and Schmolzer, {Georg M.} and Moss, {Timothy J. M.} and Hooper, {Stuart Brian} and Wallace, {Euan M.} and Polglase, {Graeme R.}",
year = "2016",
month = "8",
doi = "10.1159/000444918",
language = "English",
volume = "110",
pages = "155--162",
journal = "Neonatology",
issn = "1661-7800",
publisher = "Karger",
number = "2",

}

Ventilation-induced brain injury in preterm neonates : A review of potential therapies. / Barton, Samantha K.; Tolcos, Mary; Miller, Suzanne L.; Roehr, Charles Christoph; Schmolzer, Georg M.; Moss, Timothy J. M.; Hooper, Stuart Brian; Wallace, Euan M.; Polglase, Graeme R.

In: Neonatology, Vol. 110, No. 2, 08.2016, p. 155-162.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Ventilation-induced brain injury in preterm neonates

T2 - A review of potential therapies

AU - Barton, Samantha K.

AU - Tolcos, Mary

AU - Miller, Suzanne L.

AU - Roehr, Charles Christoph

AU - Schmolzer, Georg M.

AU - Moss, Timothy J. M.

AU - Hooper, Stuart Brian

AU - Wallace, Euan M.

AU - Polglase, Graeme R.

PY - 2016/8

Y1 - 2016/8

N2 - Mechanical ventilation is a risk factor for cerebral inflammation and brain injury in preterm neonates. The risk increases proportionally with the intensity of treatment. Recent studies have shown that cerebral inflammation and injury can be initiated in the delivery room. At present, initiation of intermittent positive pressure ventilation (IPPV) in the delivery room is one of the least controlled interventions a preterm infant will likely face. Varying pressures and volumes administered shortly after birth are sufficient to trigger pathways of ventilation-induced lung and brain injury. The pathways involved in ventilation-induced brain injury include a complex inflammatory cascade and haemodynamic instability, both of which have an impact on the brain. However, regardless of the strategy employed to deliver IPPV, any ventilation has the potential to have an impact on the immature brain. This is particularly important given that preterm infants are already at a high risk for brain injury simply due to immaturity. This highlights the importance of improving the initial respiratory support in the delivery room. We review the mechanisms of ventilation-induced brain injury and discuss the need for, and the most likely, current therapeutic agents to protect the preterm brain. These include therapies already employed clinically, such as maternal glucocorticoid therapy and allopurinol, as well as other agents, such as erythropoietin, human amnion epithelial cells and melatonin, already showing promise in preclinical studies. Their mechanisms of action are discussed, highlighting their potential for use immediately after birth.

AB - Mechanical ventilation is a risk factor for cerebral inflammation and brain injury in preterm neonates. The risk increases proportionally with the intensity of treatment. Recent studies have shown that cerebral inflammation and injury can be initiated in the delivery room. At present, initiation of intermittent positive pressure ventilation (IPPV) in the delivery room is one of the least controlled interventions a preterm infant will likely face. Varying pressures and volumes administered shortly after birth are sufficient to trigger pathways of ventilation-induced lung and brain injury. The pathways involved in ventilation-induced brain injury include a complex inflammatory cascade and haemodynamic instability, both of which have an impact on the brain. However, regardless of the strategy employed to deliver IPPV, any ventilation has the potential to have an impact on the immature brain. This is particularly important given that preterm infants are already at a high risk for brain injury simply due to immaturity. This highlights the importance of improving the initial respiratory support in the delivery room. We review the mechanisms of ventilation-induced brain injury and discuss the need for, and the most likely, current therapeutic agents to protect the preterm brain. These include therapies already employed clinically, such as maternal glucocorticoid therapy and allopurinol, as well as other agents, such as erythropoietin, human amnion epithelial cells and melatonin, already showing promise in preclinical studies. Their mechanisms of action are discussed, highlighting their potential for use immediately after birth.

KW - Brain

KW - Delivery room

KW - Neonate

KW - Resuscitation

KW - Therapy

KW - Ventilation

UR - http://www.scopus.com/inward/record.url?scp=84977658195&partnerID=8YFLogxK

U2 - 10.1159/000444918

DO - 10.1159/000444918

M3 - Article

VL - 110

SP - 155

EP - 162

JO - Neonatology

JF - Neonatology

SN - 1661-7800

IS - 2

ER -